Deciphering Mechanisms Underlying Cancer Immunogenicity

NARecruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

January 31, 2033

Study Completion Date

January 31, 2033

Conditions
Head and Neck CancerOvarian CancerCervical CancerCervical Intraepithelial Neoplasia 3Glioblastoma Multiforme of Brain StemNon Small Cell Lung CancerAnal Cancer
Interventions
OTHER

Blood samples, tumor biopsy specimens and ascites samples will be collected.

"Blood samples, tumor biopsy specimens and ascites samples will be collected at different time points (if feasible, according to the samples taken in the standard practice) for a maximum follow-up period of 5 years from baseline:~* at Baseline.~* at every surgical procedure or tumor biopsy.~* every 6 months (± 2 months) (only blood sample).~* at the time of the progression or recurrence, additional samples will be collected, and optionally at the time of the following progressions or recurrences (if applicable).~For patients undergoing a RT treatment, blood samples will be collected before the RT (i.e. at the time of planning CT-scan), at the last session of RT (± 2 days) and 3 months after the end of the RT (± 2 weeks)."

Trial Locations (3)

31059

RECRUITING

Hopital Larrey, Toulouse

RECRUITING

Hopital Rangueil, Toulouse

Unknown

RECRUITING

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03958240 - Deciphering Mechanisms Underlying Cancer Immunogenicity | Biotech Hunter | Biotech Hunter